International Collaboration for Scientific Training Launched Between The Wistar Institute and Leiden University Medical Center in the Netherlands

Wistar and Leiden University Medical Center (LUMC) formalized a memorandum of understanding between the two institutions to explore a postdoctoral training exchange program in immunology, cancer research and vaccine biology. The Wistar-Schoemaker...
15-Nov-2019 1:40 PM EST Add to Favorites

Synthetic DNA Technology Applied as a Novel Strategy for Delivery of Anti-HIV Antibodies

Wistar scientists applied synthetic DNA-based technology to drive in vivo production of broadly neutralizing anti-HIV antibodies in small and large-animal models, providing proof of concept for a simple and effective next generation approach to HIV...
8-Nov-2019 12:50 PM EST Add to Favorites

Wistar Institute Researcher Awarded American Cancer Society Research Professorship

The American Cancer Society has awarded a Research Professorship to Wistar's Dmitry l. Gabrilovich, M.D., Ph.D. This lifelong designation, accompanied by a five-year $400,000 commitment, is the most prestigious research grant made by ACS.
22-Oct-2019 10:30 AM EDT Add to Favorites

$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Wistar and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy...
17-Oct-2019 9:40 AM EDT Add to Favorites

New Mechanism Fueling Brain Metastasis Discovered at Wistar

Wistar scientists described a novel mechanism through which astrocytes, the most abundant supporting cells in the brain, also promote cancer cell growth and metastasis in the brain.
9-Oct-2019 11:05 AM EDT Add to Favorites

Targeting a Novel Regulator of Mitochondrial Cell Death Delivers Anticancer Activity in Preclinical Studies

A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types.
2-Oct-2019 3:05 PM EDT Add to Favorites

NIH New Innovator Award Given to Wistar Researcher to Unravel the Metabolic Link Between Diet, Alcohol Consumption and Cancer

The National Institutes of Health (NIH) today announced that Zachary T. Schug, Ph.D., assistant professor in the Molecular & Cellular Oncogenesis Program at Wistar, was awarded the prestigious NIH Director’s New Innovator Award in support of his...
1-Oct-2019 9:40 AM EDT Add to Favorites

Wistar Receives More than $12 Million to Fund Innovative Clinical Research on the Impact of Opioid Use on Response to Therapy in People Living with HIV

Wistar was awarded two major grants totaling more than $12 million from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to fund an international multidisciplinary clinical research consortium spearheaded by...
24-Sep-2019 10:05 AM EDT Add to Favorites

see all news